Table 2.
Teaching points
| CYP24A1 pathogenic variants are a cause of vitamin D−mediated hypercalcemia, which is exacerbated by pregnancy, particularly following delivery |
| Maternal and neonatal complications have been described, including renal dysfunction, hypertensive disorders of pregnancy and preeclampsia, preterm delivery, and fetal growth restriction and death |
| Regulation of vitamin D and calcium intake is key |
| Treatment options in pregnancy are limited due to safety concerns Calcitonin was used in this case and appears safe and effective |
| Management of gestational hypercalcemia reduced complications, particularly in the offspring |